FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367016850> ?p ?o ?g. }

• W4367016850 abstract "Most patients with diffuse large B-cell lymphoma (DLBCL) will be cured with up-front chemoimmunotherapy, but 30%-40% of patients will experience relapsed disease. Historically, salvage chemotherapy followed by autologous stem-cell transplant (ASCT) was the mainstay of treatment for these patients. However, research has demonstrated that patients with primary refractory or early relapsed (R/R; high-risk) DLBCL do not benefit from ASCT, prompting investigation into other options. With the advent of chimeric antigen receptor (CAR) T-cell therapy, treatment of R/R DLBCL has changed dramatically. With positive outcomes in the TRANSFORM and ZUMA-7 trials with manageable toxicity profiles, approval was obtained for lisocabtagene maraleucel (liso-cel) and axicabtagene ciloleucel (axi-cel) as second-line therapies for high-risk R/R DLBCL. However, these trials required patients to be medically fit for ASCT. In PILOT, liso-cel was deemed a reasonable treatment option for R/R transplant-ineligible patients. We recommend either axi-cel or liso-cel for fit patients with high-risk R/R DLBCL or liso-cel for unfit R/R patients as a second-line therapy. If CAR T-cell therapy is not an option, we recommend consideration of either ASCT if the patient has chemosensitive disease and is fit or clinical trial if the patient is unfit or has chemoresistant disease. If trials are not an option, alternative treatments are available. With the advent of additional therapies such as bispecific T-cell–engaging antibodies, the treatment landscape of R/R DLBCL may be upended. There continue to be many unanswered questions in the management of patients with R/R DLBCL, but given the promise of cellular therapies, outcomes are more optimistic in this group with historically dismal survival." @default.
• W4367016850 created "2023-04-27" @default.
• W4367016850 creator A5000537427 @default.
• W4367016850 creator A5085547392 @default.
• W4367016850 date "2023-01-01" @default.
• W4367016850 modified "2023-10-01" @default.
• W4367016850 title "Management Considerations for Patients With Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma" @default.
• W4367016850 cites W1997353354 @default.
• W4367016850 cites W2058015212 @default.
• W4367016850 cites W2077320602 @default.
• W4367016850 cites W2133345449 @default.
• W4367016850 cites W2145453495 @default.
• W4367016850 cites W2150129319 @default.
• W4367016850 cites W2150587745 @default.
• W4367016850 cites W2532606512 @default.
• W4367016850 cites W2556342759 @default.
• W4367016850 cites W2744261860 @default.
• W4367016850 cites W2773804840 @default.
• W4367016850 cites W2903062212 @default.
• W4367016850 cites W2984927918 @default.
• W4367016850 cites W3034162969 @default.
• W4367016850 cites W3082855561 @default.
• W4367016850 cites W3137124431 @default.
• W4367016850 cites W3137447968 @default.
• W4367016850 cites W3161133732 @default.
• W4367016850 cites W3176363517 @default.
• W4367016850 cites W3201013983 @default.
• W4367016850 cites W3203427599 @default.
• W4367016850 cites W3212349863 @default.
• W4367016850 cites W3216840960 @default.
• W4367016850 cites W4200014243 @default.
• W4367016850 cites W4200201081 @default.
• W4367016850 cites W4200303223 @default.
• W4367016850 cites W4283023614 @default.
• W4367016850 cites W4285098878 @default.
• W4367016850 cites W4310107143 @default.
• W4367016850 cites W4311537867 @default.
• W4367016850 cites W4312094698 @default.
• W4367016850 doi "https://doi.org/10.1200/edbk_390802" @default.
• W4367016850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37098236" @default.
• W4367016850 hasPublicationYear "2023" @default.
• W4367016850 type Work @default.
• W4367016850 citedByCount "0" @default.
• W4367016850 crossrefType "journal-article" @default.
• W4367016850 hasAuthorship W4367016850A5000537427 @default.
• W4367016850 hasAuthorship W4367016850A5085547392 @default.
• W4367016850 hasConcept C121332964 @default.
• W4367016850 hasConcept C126322002 @default.
• W4367016850 hasConcept C141071460 @default.
• W4367016850 hasConcept C142424586 @default.
• W4367016850 hasConcept C143998085 @default.
• W4367016850 hasConcept C2776694085 @default.
• W4367016850 hasConcept C2778559949 @default.
• W4367016850 hasConcept C2779338263 @default.
• W4367016850 hasConcept C2780653079 @default.
• W4367016850 hasConcept C2780775027 @default.
• W4367016850 hasConcept C2780790343 @default.
• W4367016850 hasConcept C535046627 @default.
• W4367016850 hasConcept C71924100 @default.
• W4367016850 hasConcept C87355193 @default.
• W4367016850 hasConceptScore W4367016850C121332964 @default.
• W4367016850 hasConceptScore W4367016850C126322002 @default.
• W4367016850 hasConceptScore W4367016850C141071460 @default.
• W4367016850 hasConceptScore W4367016850C142424586 @default.
• W4367016850 hasConceptScore W4367016850C143998085 @default.
• W4367016850 hasConceptScore W4367016850C2776694085 @default.
• W4367016850 hasConceptScore W4367016850C2778559949 @default.
• W4367016850 hasConceptScore W4367016850C2779338263 @default.
• W4367016850 hasConceptScore W4367016850C2780653079 @default.
• W4367016850 hasConceptScore W4367016850C2780775027 @default.
• W4367016850 hasConceptScore W4367016850C2780790343 @default.
• W4367016850 hasConceptScore W4367016850C535046627 @default.
• W4367016850 hasConceptScore W4367016850C71924100 @default.
• W4367016850 hasConceptScore W4367016850C87355193 @default.
• W4367016850 hasIssue "43" @default.
• W4367016850 hasLocation W43670168501 @default.
• W4367016850 hasLocation W43670168502 @default.
• W4367016850 hasOpenAccess W4367016850 @default.
• W4367016850 hasPrimaryLocation W43670168501 @default.
• W4367016850 hasRelatedWork W1973891791 @default.
• W4367016850 hasRelatedWork W2102241654 @default.
• W4367016850 hasRelatedWork W2272592620 @default.
• W4367016850 hasRelatedWork W2403773722 @default.
• W4367016850 hasRelatedWork W2469233091 @default.
• W4367016850 hasRelatedWork W2555972665 @default.
• W4367016850 hasRelatedWork W2563160427 @default.
• W4367016850 hasRelatedWork W2800561786 @default.
• W4367016850 hasRelatedWork W3001665703 @default.
• W4367016850 hasRelatedWork W4224269840 @default.
• W4367016850 isParatext "false" @default.
• W4367016850 isRetracted "false" @default.
• W4367016850 workType "article" @default.